肝硬化住院患者急性肾损伤的流行病学与结局变化:美国人群研究
AKI患病率从2004年15%升至2016年30%,住院费用更高、住院时间更长,且死亡风险显著增加(调整OR 3.75,95%CI 3.71–3.79)。
要点
- 肝硬化住院患者中AKI患病率从2004年15%升至2016年30%。
- 合并AKI者住院费用中位数13,127美元、住院6天,均高于无AKI者。
- AKI使肝硬化住院死亡风险增加至3.75倍(调整OR 3.75,95%CI 3.71–3.79)。
核心结论
- 肝硬化住院患者AKI患病率显著增加,AKI大幅增加医疗负担且死亡风险仍高。
研究设计与样本
- 基于2004–2016年美国全国住院样本(NIS)的回顾性人群研究,使用ICD-9和ICD-10编码识别肝硬化伴或不伴AKI的住院记录,采用回归分析趋势与关联。
主要发现
- AKI住院费用中位数13,127美元(IQR 7,367–24,891),无AKI为8,079美元(IQR 4,956–13,693)。
- AKI住院时间中位数6天(IQR 3–11),无AKI为4天(IQR 2–7)。
- AKI患病率从2004年15%升至2016年30%。
- 慢性肾病(CKD)与AKI独立强相关(调整OR 3.75,95%CI 3.72–3.77)。
关键数值与推荐
- AKI住院死亡调整OR 3.75(95%CI 3.71–3.79)。
- AKI在感染和门静脉高压相关并发症等肝硬化亚组中均增加死亡风险。
临床怎么用
- 肝硬化住院患者应关注AKI发生,尤其合并CKD、感染或门静脉高压并发症者。
- AKI与更高医疗负担和死亡风险相关,提示需加强早期识别与干预。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Acute kidney injury (AKI) is a significant clinical event in cirrhosis yet contemporary population-based studies on the impact of AKI on hospitalized cirrhotics are lacking. We aimed to characterize longitudinal trends in incidence, healthcare burden and outcomes of hospitalized cirrhotics with and without AKI using a nationally representative dataset. METHODS: Using the 2004-2016 National Inpatient Sample (NIS), admissions for cirrhosis with and without AKI were identified using ICD-9 and ICD-10 codes. Regression analysis was used to analyze the trends in hospitalizations, costs, length of stay and inpatient mortality. Descriptive statistics, simple and multivariable logistic regression were used to assess associations between individual characteristics, comorbidities, and cirrhosis complications with AKI and death. RESULTS: In over 3.6 million admissions for cirrhosis, 22% had AKI. AKI admissions were more costly (median $13,127 [IQR $7,367-$24,891] vs. $8,079 [IQR $4,956-$13,693]) and longer (median 6 [IQR 3-11] days vs. 4 [IQR 2-7] days). Over time, AKI prevalence doubled from 15% in 2004 to 30% in 2016. CKD was independently and strongly associated with AKI (adjusted odds ratio 3.75; 95% CI 3.72-3.77). Importantly, AKI admissions were 3.75 times more likely to result in death (adjusted odds ratio 3.75; 95% CI 3.71-3.79) and presence of AKI increased risk of mortality in key subgroups of cirrhosis, such as those with infections and portal hypertension-related complications. CONCLUSIONS: The prevalence of AKI is significantly increased among hospitalized cirrhotics. AKI substantially increases the healthcare burden associated with cirrhosis. Despite advances in cirrhosis care, a significant gap remains in outcomes between cirrhotics with and without AKI, suggesting that AKI continues to represent a major clinical challenge. LAY SUMMARY: Sudden damage to the kidneys is becoming more common in people who are hospitalized and have cirrhosis. Despite advances in cirrhosis care, those with damage to the kidneys remain at higher risk of dying.
引用
- Desai AP, Knapp SM, Orman ES, et al. Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. J Hepatol. 2020. PMID: 32387698. doi:10.1016/j.jhep.2020.04.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。